Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium von LEON, Martin B, PIAZZA, Nicoto, MOREL, Marie-Angèle, PETERSEN, John, POPMA, Jeffrey J, TAKKENBERG, Johanna J. M, VAHANIAN, Alec, VAN ES, Gerrit-Anne, VRANCKX, Pascal, WEBB, John G, WINDECKER, Stephan, SERRUYS, Patrick W, NIKOLSKY, Eugenia, BLACKSTONE, Eugene H, CUTLIP, Donald E, PIETER KAPPETEIN, Arie, KRUCOFF, Mitchell W, MACK, Michael, MEHRAN, Roxana, MILLER, Craig

Volltext

Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specif... von Costa, Francesco, Vranckx, Pascal, Leonardi, Sergio, Moscarella, Elisabetta, Ando, Giuseppe, Calabro, Paolo, Oreto, Giuseppe, Zijlstra, Felix, Valgimigli, Marco

Volltext

Should duration of dual antiplatelet therapy depend on the type and/or potency of implanted stent? A pre-specified analysis from the PROlonging Dual antiplatelet treatment after Gr... von Valgimigli, Marco, Borghesi, Marco, Tebaldi, Matteo, Vranckx, Pascal, Parrinello, Giovanni, Ferrari, Roberto

Volltext

Effects of pre‐hospital clopidogrel administration on early and late residual platelet reactivity in ST‐segment elevation myocardial infarction patients undergoing primary interven... von BISCAGLIA, S., TEBALDI, M., VRANCKX, P., CAMPO, G., VALGIMIGLI, M.

Volltext

2018 ESC/EACTS Guidelines onmyocardial revascularization (vol 40, pg 87, 2019) von Neumann, FJ, Sousa-Uva, M, Ahlsson, A, Alfonso, F, Banning, AP, Benedetto, U, Byrne, RA, Collet, JP, Falk, V, Head, SJ

Volltext

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes von Valgimigli, Marco, Frigoli, Enrico, Leonardi, Sergio, Rothenbühler, Martina, Gagnor, Andrea, Calabrò, Paolo, Garducci, Stefano, Rubartelli, Paolo, Briguori, Carlo, Andò, Giuseppe, Repetto, Alessandra, Limbruno, Ugo, Garbo, Roberto, Sganzerla, Paolo, Russo, Filippo, Lupi, Alessandro, Cortese, Bernardo, Ausiello, Arturo, Ierna, Salvatore, Esposito, Giovanni, Presbitero, Patrizia, Santarelli, Andrea, Sardella, Gennaro, Varbella, Ferdinando, Tresoldi, Simone, de Cesare, Nicoletta, Rigattieri, Stefano, Zingarelli, Antonio, Tosi, Paolo, van ’t Hof, Arnoud, Boccuzzi, Giacomo, Omerovic, Elmir, Sabaté, Manel, Heg, Dik, Jüni, Peter, Vranckx, Pascal

Volltext

Clinical development of bivalirudin (Angiox®): rationale for thrombin-specific anticoagulation in percutaneous coronary intervention and acute coronary syndromes von Serruys, P. W., Vranckx, P., Allikmets, K.

Volltext

Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2) von Kappetein, Arie Pieter, Head, Stuart J., Généreux, Philippe, Piazza, Nicolo, van Mieghem, Nicolas M., Blackstone, Eugene H., Brott, Thomas G., Cohen, David J., Cutlip, Donald E., van Es, Gerrit-Anne, Hahn, Rebecca T., Kirtane, Ajay J., Krucoff, Mitchell W., Kodali, Susheel, Mack, Michael J., Mehran, Roxana, Rodés-Cabau, Josep, Vranckx, Pascal, Webb, John G., Windecker, Stephan, Serruys, Patrick W., Leon, Martin B.

Volltext

Doporučení ESC pro léčbu akutních koronárních syndromů 2023 von RA, Byrne, Rossello, X, JJ, Coughlan, Barbato, E, Berry, C, Chieffo, A, MJ, Claeys, GA, Dan, MR, Dweck, Galbraith, M, Gilard, M, Hinterbuchner, L, EA, Jankowska, Jüni, P, Kimura, T, Kunadian, V, Leosdottir, M, Lorusso, R, RFE, Pedretti, AG, Rigopoulos, Gimenez, Rubini M, Thiele, H, Vranckx, P, Wassmann, S, NK, Wenger, Ibanez, B, Kala, Petr, Ošťádal, Petr, Moťovská, Zuzana, Mates, Martin, Vondráková, Dagmar, Bělohlávek, Jan, Fila, Petr, Varvařovský, Ivo

Volltext

Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an ear... von Crea, Filippo

Volltext

European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: insights from an international survey von Van Edom, C, Castelein, T, Gramegna, M, Huber, K, Leonardi, S, Mueller, T, Pappalardo, F, Price, S, Schaubroeck, H, Schrage, B, Swol, J, Tavazzi, G, Vercaemst, L, Vranckx, P, Vandenbriele, C

Volltext

Edoxaban in atrial fibrillation with PCI by ACS or stable CAD presentation: a pre-specified analysis of the ENTRUST-AF PCI trial von Vranckx, P, Valgimigli, M, Eckardt, L, Lewalter, T, Laeis, P, Reimitz, P.E, Smolnik, R, Zierhut, W, Tijssen, J, Goette, A

Volltext

Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specifi... von Valgimigli, Marco, Tebaldi, Matteo, Borghesi, Marco, Vranckx, Pascal, Campo, Gianluca, Tumscitz, Carlo, Cangiano, Elisa, Minarelli, Monica, Scalone, Antonella, Cavazza, Caterina, Marchesini, Jlenia, Parrinello, Giovanni

Volltext

Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention: Results From the Double-Blind,... von VALGIMIGLI, Marco, CAMPO, Gianluca, COLANGELO, Salvatore, BRUGALETTA, Salvatore, PARRINELLO, Giovanni, PERCOCO, Gianfranco, FERRARI, Roberto, DE CESARE, Nicoletta, MELIGA, Emanuele, VRANCKX, Pascal, FURGIERI, Alessandro, ANGIOLILLO, Dominick J, SABATE, Manel, HAMON, Martial, REPETTO, Alessandra

Volltext

Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial von Mega, JL, MD, Braunwald, E, Prof, Mohanavelu, S, MS, Burton, P, MD, Poulter, R, MB, Misselwitz, F, MD, Hricak, V, Prof, Barnathan, ES, MD, Bordes, P, MD, Witkowski, A, Prof, Markov, V, Prof, Oppenheimer, L, PhD, Gibson, CM, MD

Volltext

P1952Value of GRACE risk score in risk stratification in acute coronary syndrome patients undergoing PCI in the Global Leaders study von Komiyama, H, Chichareon, P, Hamm, C, Juni, P, Valgimigli, M, Vranckx, P, Windecker, S, Onuma, Y, Stegg, G, Serruys, P

Volltext

Efficacy and safety of early aspirin withdrawal and continuation of ticagrelor monotherapy post PCI for STEMI. A post hoc analysis of the randomized global leaders trial von Gamal Setih, A, Hara, H, Tomaniak, M, Lunardi, M, Gao, C, Ono, M, Kawashima, H, Juni, P, Vranckx, P, Windecker, S, Hamm, C, Gabriel Steg, P, Onuma, Y, Serruys, P

Volltext

P6408Potential benefit of ticagrelor monotherapy for patients with hypertension undergoing percutaneous coronary intervention: insights from the Global Leaders trial von Modolo, R, Chichareon, P, De Faria, A P, Steg, P G, Hamm, C, Vranckx, P, Valgimigli, M, Windecker, S, Onuma, Y, Serruys, P W

Volltext

Ticagrelor monotherapy beyond 1 month versus standard dual antiplatelet therapy after drug-eluting coronary stenting: a pre-specified per-protocol analysis of the GLOBAL LEADERS tr... von Gragnano, F, Zwahlen, M, Vranckx, P, Juni, P, Heg, D, Hamm, C, Steg, P.G, Hagenbuch, N, Gargiulo, G, Van Geuns, R.J, Huber, K, Van Amsterdam, R, Serruys, P.W, Valgimigli, M, Windecker, S

Volltext

Anticoagulation for percutaneous ventricular assist device-supported cardiogenic shock von Vandenbriele, C, Arachchillage, DJ, Frederiks, P, Giustino, G, Gorog, DA, Gramegna, M, Janssens, S, Meyns, B, Polzin, A, Scandroglio, M, Schrage, B, Stone, GW, Tavazzi, G, Vanassche, T, Vranckx, P, Westermann, D, Price, S, Chieffo, A

Volltext